Physicians in Türkiye reported a case where a heavily pre-treated multiple myeloma patient achieved complete, durable remission of CNS involvement after receiving a BCMA-targeted bispecific antibody alongside intrathecal chemotherapy. The report highlights a potential path for refractory CNS myeloma using combined systemic and CNS-directed treatment.